Literature DB >> 23153478

Diet-induced antisecretory factor prevents intracranial hypertension in a dosage-dependent manner.

Ewa Johansson1, Mohamed Al-Olama, Hans-Arne Hansson, Stefan Lange, Eva Jennische.   

Abstract

Intake of specially processed cereal (SPC) stimulates endogenous antisecretory factor (AF) activity, and SPC intake has proven to be beneficial for a number of clinical conditions. The aim of the present study was to investigate the dosage relationship between SPC intake and plasma AF activity and to further correlate achieved AF levels to a biological effect. SPC was fed to rats in concentrations of 5, 10 or 15% for 2 weeks. A further group was fed 5% SPC for 4 weeks. AF activity and the complement factors C3c and factor H were analysed in plasma after the feeding period. Groups of rats fed the various SPC concentrations were subjected to a standardised freezing brain injury, known to induce increases in intracranial pressure (ICP). The AF activity in plasma increased after intake of SPC, in a dosage- and time-dependent manner. The complement factors C3c and factor H increased in a time-dependent manner. Measurements of ICP in animals fed with SPC prior to the brain injury showed that the ICP was significantly lower, compared with that of injured rats fed with a standard feed, and that the change was dose and time dependent. AF activity increases, in a dosage- and time-dependent manner, after intake of SPC. The inverse relationship between ICP after a head injury and the percentage of SPC in the feed indicate that the protective effect is, to a large extent, due to AF.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23153478     DOI: 10.1017/S0007114512004552

Source DB:  PubMed          Journal:  Br J Nutr        ISSN: 0007-1145            Impact factor:   3.718


  7 in total

1.  Antisecretory Factor-Mediated Inhibition of Cell Volume Dynamics Produces Antitumor Activity in Glioblastoma.

Authors:  Shirin Ilkhanizadeh; Hanna Sabelström; Yekaterina A Miroshnikova; Aaron Frantz; Wen Zhu; Aurora Idilli; Jon N Lakins; Christin Schmidt; David A Quigley; Trenten Fenster; Edith Yuan; Jacqueline R Trzeciak; Supna Saxena; Olle R Lindberg; Janna K Mouw; Jason A Burdick; Sergey Magnitsky; Mitchel S Berger; Joanna J Phillips; Daniele Arosio; Dandan Sun; Valerie M Weaver; William A Weiss; Anders I Persson
Journal:  Mol Cancer Res       Date:  2018-02-05       Impact factor: 5.852

2.  Food-induced changes of lipids in rat neuronal tissue visualized by ToF-SIMS imaging.

Authors:  Masoumeh Dowlatshahi Pour; Eva Jennische; Stefan Lange; Andrew G Ewing; Per Malmberg
Journal:  Sci Rep       Date:  2016-09-06       Impact factor: 4.379

3.  Reaction of complement factors and proteasomes in experimental encephalitis.

Authors:  Stefan Lange; Tomas Bergström; Ewa Johansson; Merna Oshalim; Ivar Lönnroth
Journal:  J Neurovirol       Date:  2016-12-02       Impact factor: 2.643

4.  Increased level of compleasomes in cerebrospinal fluid of patients with herpes simplex encephalitis.

Authors:  Ewa Johansson; Stefan Lange; Tomas Bergström; Merna Oshalim; Ivar Lönnroth; Marie Studahl
Journal:  J Neurovirol       Date:  2018-08-09       Impact factor: 2.643

5.  Does the antisecretory peptide AF-16 reduce lung oedema in experimental ARDS?

Authors:  Annelie Barrueta Tenhunen; Fabrizia Massaro; Hans Arne Hansson; Ricardo Feinstein; Anders Larsson; Anders Larsson; Gaetano Perchiazzi
Journal:  Ups J Med Sci       Date:  2019-11-08       Impact factor: 2.384

6.  The endogenous peptide antisecretory factor promotes tonic GABAergic signaling in CA1 stratum radiatum interneurons.

Authors:  Joakim Strandberg; Catarina Lindquist; Stefan Lange; Fredrik Asztely; Eric Hanse
Journal:  Front Cell Neurosci       Date:  2014-01-28       Impact factor: 5.505

7.  Uptake of the antisecretory factor peptide AF-16 in rat blood and cerebrospinal fluid and effects on elevated intracranial pressure.

Authors:  Mohamed Al-Olama; Stefan Lange; Ivar Lönnroth; Kliment Gatzinsky; Eva Jennische
Journal:  Acta Neurochir (Wien)       Date:  2014-09-24       Impact factor: 2.216

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.